Fig. 3: Overall survival after CART progression for DHL vs DEL vs other.
CART chimeric antigen receptor T-cell therapy, DEL double expressor lymphoma, DHL double hit lymphoma, Mon months, No number, OS overall survival.
Fig. 3: Overall survival after CART progression for DHL vs DEL vs other. | Blood Cancer Journal
